QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients
Crossref DOI link: https://doi.org/10.1007/s00415-016-8058-7
Published Online: 2016-02-25
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ziemssen, Tjalf
Calabrese, Pasquale
Penner, Iris-Katharina
Apfel, Rainer
Text and Data Mining valid from 2016-02-25